Results 101 to 110 of about 14,550 (189)
Irina Petrache1, Joud Hajjar1, Michael Campos21Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA; 2Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Miller School of Medicine ...
Campos, Michael +5 more
core
The liver transplant waitlist mortality for infants (age < 1 year) is currently the highest among all ages. ABO incompatible (ABOi) liver‐transplantation is one of the strategies to increase transplantation rate in infants and can be safely performed in children less than 1 year of age without plasmapheresis, with excellent long‐term outcomes. ABSTRACT
Heli Bhatt +9 more
wiley +1 more source
Landy V Luna Diaz,1 Isabella Iupe,1 Bruno Zavala,1 Kira C Balestrini,1 Andrea Guerrero,1 Gregory Holt,1,2 Rafael Calderon-Candelario,1,2 Mehdi Mirsaeidi,1,2 Michael Campos1,21Miami Veterans Administration Medical Center, Miami, FL, 2Division of Pulmonary,
Luna Diaz LV +8 more
core
When ‘Liver Enzymes’ Are Not Hepatic: Late‐Onset Pompe Disease
ABSTRACT Elevated liver function tests are commonly attributed to hepatic disease but may reflect extrahepatic pathology. We describe the case of an 18‐year‐old athletic woman with a 2‐year history of elevated aspartate aminotransferase (AST), alanine aminotransferase (ALT) and creatine kinase (CK) levels, initially investigated extensively for hepatic
Shauna Madigan +2 more
wiley +1 more source
Background and Objective: Alpha-1 antitrypsin deficiency is recognized as a etiological base in lung injury. Therefore this study was performed to determine plasma level of alpha-1 antitrypsin in war victims exposed to sulfur mustard gas.
Majid Shohrati (PhD) +3 more
doaj
Introduction: Alpha-1 antitrypsin (AAT) is a glycoprotein produced by liver, belonging to the serine protease inhibitor family. Alpha-1 antitrypsin deficiency (AATD) is very common autosomal recessive genetic disease caused by point mutation in ...
Dawid Kościołek +9 more
doaj +1 more source
Therapeutics: Gene Therapy for Alpha-1 Antitrypsin Deficiency
This review seeks to give an overview of alpha-1 antitrypsin deficiency, including the different disease phenotypes that it encompasses. We then describe the different therapeutic endeavors that have been undertaken to address these different phenotypes.
Flotte, Terence R., Gruntman, Alisha M
core +1 more source
Liver Disease in Alpha-1-Antitrypsin Deficiency
Alpha-1-antitrypsin deficiency is a hereditary disorder characterized by a deficiency of the primarily liver-produced enzyme alpha-1-antitrypsin. In children, it remains the most common genetic cause of liver disease.
Alice Turner +3 more
core +1 more source
Liver:: Alpha-1-Antitrypsin Deficiency.
Alpha-1-antitrypsin deficiency. COMMENT: Bile stasis and a micronodular cirrhosis are seen in this example of enzyme deficiency disease.
MUSC Department of Pathology and Laboratory Medicine
core
Pulmonary artery aneurysm as a rare manifestation of Alpha-1 antitrypsin deficiency
Alpha-1 antitrypsin is a relatively well-known genetic disease known to primarily affect the lungs and liver. Extrapulmonary manifestations of this disease have been reported, including vascular aneurysms.
Mark A. Colantonio +2 more
doaj +1 more source

